187 related articles for article (PubMed ID: 11821960)
1. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
2. Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma.
Koch CA; Brouwers FM; Vortmeyer AO; Tannapfel A; Libutti SK; Zhuang Z; Pacak K; Neumann HP; Paschke R
BMC Cancer; 2006 May; 6():131. PubMed ID: 16707008
[TBL] [Abstract][Full Text] [Related]
3. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
4. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
5. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
6. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
[TBL] [Abstract][Full Text] [Related]
7. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
8. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
9. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
10. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
Assadi F; Brackbill EL
Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
[TBL] [Abstract][Full Text] [Related]
11. Germ-line mutations in nonsyndromic pheochromocytoma.
Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
[TBL] [Abstract][Full Text] [Related]
12. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
14. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
15. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
Vortmeyer AO; Huang SC; Pack SD; Koch CA; Lubensky IA; Oldfield EH; Zhuang Z
Oncogene; 2002 Feb; 21(8):1167-70. PubMed ID: 11850836
[TBL] [Abstract][Full Text] [Related]
16. Genetic aspects of pheochromocytoma.
Koch CA; Vortmeyer AO; Huang SC; Alesci S; Zhuang Z; Pacak K
Endocr Regul; 2001 Mar; 35(1):43-52. PubMed ID: 11308996
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
[TBL] [Abstract][Full Text] [Related]
18. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
19. Differences in allelic distribution of two polymorphisms in the VHL-associated gene CUL2 in pheochromocytoma patients without somatic CUL2 mutations.
Duerr EM; Gimm O; Neuberg DS; Kum JB; Clifford SC; Toledo SP; Maher ER; Dahia PL; Eng C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3207-11. PubMed ID: 10487688
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]